MedPath

VIRGINIA COMMONWEALTH UNIVERSITY

VIRGINIA COMMONWEALTH UNIVERSITY logo
🇺🇸United States
Ownership
Private
Established
1838-01-01
Employees
10K
Market Cap
-
Website
http://www.vcu.edu

Vascular Responses to Sympathetic Activation and Altered Shear Rate: The Impact of Hypertension and Sodium Intake

Not Applicable
Completed
Conditions
Hypertension
Interventions
Dietary Supplement: Salt Pills
Dietary Supplement: Placebo Pills
First Posted Date
2018-06-15
Last Posted Date
2023-01-13
Lead Sponsor
Virginia Commonwealth University
Target Recruit Count
34
Registration Number
NCT03558022
Locations
🇺🇸

Virginia Commonwealth University, Richmond, Virginia, United States

Effects of Curcumin Supplementation on Gut Barrier Function in Patients With Metabolic Syndrome

Not Applicable
Completed
Conditions
Obesity
High Cholesterol
Heart Diseases
High Blood Pressure
Type2 Diabetes
Interventions
Dietary Supplement: Curcumin
First Posted Date
2018-05-31
Last Posted Date
2021-01-26
Lead Sponsor
Virginia Commonwealth University
Target Recruit Count
15
Registration Number
NCT03542240
Locations
🇺🇸

Virginia Commonwealth University, Richmond, Virginia, United States

The Impact of Physical (In)Activity on Sleep Quality

Not Applicable
Completed
Conditions
Sleep
Interventions
Behavioral: Reduced Physical Activity
First Posted Date
2018-05-03
Last Posted Date
2020-02-10
Lead Sponsor
Virginia Commonwealth University
Target Recruit Count
33
Registration Number
NCT03514953
Locations
🇺🇸

Virginia Commonwealth University, Richmond, Virginia, United States

Feasibility and Validation of a Standard Phenotyping Assessment Battery

Completed
Conditions
Opioid-use Disorder
Cocaine Use Disorder
Healthy Controls
Marijuana Use Disorder
First Posted Date
2018-04-12
Last Posted Date
2021-08-04
Lead Sponsor
Virginia Commonwealth University
Target Recruit Count
368
Registration Number
NCT03495869
Locations
🇺🇸

VCU Institute for Drug and Alcohol Studies, Richmond, Virginia, United States

The Influence of Electronic (ECIG) Heater Resistance on ECIG Acute Effects

Not Applicable
Completed
Conditions
Nicotine Dependence
Interventions
Other: ECIG Session
First Posted Date
2018-04-12
Last Posted Date
2019-05-09
Lead Sponsor
Virginia Commonwealth University
Target Recruit Count
38
Registration Number
NCT03496116
Locations
🇺🇸

Virginia Commonwealth University, Richmond, Virginia, United States

Feasibility of the Utilization of Buprenorphine in the Emergency Room to Treat Clinical Opioid Withdrawal

Early Phase 1
Completed
Conditions
Drug Overdose
Opioid Withdrawal
Opioid-use Disorder
Interventions
First Posted Date
2018-04-05
Last Posted Date
2018-12-13
Lead Sponsor
Virginia Commonwealth University
Target Recruit Count
3
Registration Number
NCT03489161
Locations
🇺🇸

Virginia Commonwealth University, Richmond, Virginia, United States

Music Distraction and Its Influence on Anesthetic Requirements During Elective Knee Surgery

Not Applicable
Completed
Conditions
Surgery
Anesthesia; Functional
Interventions
Other: Music
Other: Headphones
Drug: Propofol
First Posted Date
2018-04-03
Last Posted Date
2023-05-25
Lead Sponsor
Virginia Commonwealth University
Target Recruit Count
36
Registration Number
NCT03486106
Locations
🇺🇸

Virginia Commonwealth University, Richmond, Virginia, United States

Stress Reduction Training for Emotion Regulation and Well-Being

Not Applicable
Completed
Conditions
Stress Reduction
Interventions
Behavioral: Mindfulness Training (MT)
Behavioral: Active Coping Training (CT)
First Posted Date
2018-04-02
Last Posted Date
2020-02-19
Lead Sponsor
Virginia Commonwealth University
Target Recruit Count
21
Registration Number
NCT03485807
Locations
🇺🇸

Virginia Commonwealth University, Richmond, Virginia, United States

Pharmacist-driven CGM Use in the Uninsured Population

Not Applicable
Completed
Conditions
Diabetes Mellitus
Interventions
Device: FreeStyle LibrePro CGM
First Posted Date
2018-03-26
Last Posted Date
2021-02-05
Lead Sponsor
Virginia Commonwealth University
Target Recruit Count
28
Registration Number
NCT03477838
Locations
🇺🇸

Virginia Commonwealth University, Richmond, Virginia, United States

Oral vs Intravenous Diltiazem for Rapid Atrial Fibrillation/Flutter Trial

Phase 4
Completed
Conditions
Atrial Fibrillation and Flutter
Interventions
Drug: Diltiazem Injectable Product
Drug: Diltiazem Oral Product
First Posted Date
2018-03-21
Last Posted Date
2023-03-01
Lead Sponsor
Virginia Commonwealth University
Target Recruit Count
19
Registration Number
NCT03472495
Locations
🇺🇸

Virginia Commonwealth University, Richmond, Virginia, United States

© Copyright 2025. All Rights Reserved by MedPath